EU-India trade deal could be agreed by February, Merz says

German Chancellor Friedrich Merz said EU leaders could sign a EU-India free trade agreement by the end of January, signaling accelerated talks after recent high-level negotiations; India is touted as the G20’s fastest-growing economy and a pivotal Indo-Pacific partner. Key sticking points remain the sustainability chapter and dispute-settlement tied to green standards, and India objects to the EU’s Carbon Border Adjustment Mechanism, while the EU’s broader diversification agenda (including the Mercosur deal) is provoking domestic political turmoil in France. For investors, a concluded EU-India FTA would support trade diversification away from the US and China and could ease supply-chain and market-access frictions, but timing, political resistance and regulatory disputes mean near-term implementation risk persists.

Analysis

Market structure: A concluded EU–India FTA would structurally favour Indian exporters (IT, pharmaceuticals, auto components, textiles) and EU capital goods/luxury exporters by lowering barriers; expect a graduated export lift for Indian goods/services of ~5–15% over 12–36 months concentrated in services and labour‑intensive goods. Domestic EU agriculture (notably French producers) is the principal loser with localized price/volume pressure potentially 3–10% in affected crop segments. On cross‑assets, a signed deal should tighten EM sovereign spreads (India 5y spreads -15–40bp) and support INR appreciation in a 2–6% range on initial news, while eurozone yields see only modest structural change.

Risk assessment: Key tail risks include French political backlash or a CBAM‑sustainability impasse that delays ratification (probability 20–30%), and US/China escalation that reroutes diversification incentives. Immediate market impact is likely muted (days), the signing is a short‑term catalyst (weeks/months) but economic effects unfold over 1–3 years; hidden dependencies include national ratifications, rules‑of‑origin design and India’s retained sectoral protections which can limit goods access. Accelerants: an EU summit/signature by end‑Jan–Feb or rapid ratifications; reversals stem from legal disputes or punitive CBAM carve‑outs.

Trade implications: Tactical: overweight India exposure (equity and FX) and select autos/IT/pharma names; use long INDA (iShares MSCI India) and selective longs in INFY (Infosys) and TTM (Tata Motors) sized 1–3% each with 12‑month targets +15–25%. Relative value: pair long INDA vs short FEZ (Euro Stoxx 50 ETF) to isolate India vs broad EU political risk. Options: use 3‑6 month INR call spread (or USD/INR forward long) to capture a 2–6% move while capping cost.

Contrarian angles: The market will overstate near‑term wins — FTAs historically (EU–Vietnam) take 3–5 years to generate material trade flow changes, so avoid full conviction directional long exposure without hedges. CBAM disputes and India’s sectoral protections are underpriced risks; if INR rallies >4% quickly, exporters’ margins could compress and require re‑hedging. Use option structures and pair trades to express the view while limiting political/regulatory shock risk.

Key Decisions for Investors

• Establish a 2–3% portfolio long in INDA (iShares MSCI India) over next 30–90 days, target +15–25% over 12 months; set stop‑loss at -10% and trim 50% on +12% gains.
• Initiate 1–2% long positions in INFY (Infosys, INFY) and TTM (Tata Motors, TTM) split 60/40 for service vs goods exposure; use 9–12 month horizon, take profits at +20% and cut losses at -12%.
• Implement a pair trade: long INDA (1.5%) / short FEZ (1.5%) to isolate India upside vs EU political risk; review after EU summit (target re‑balance at 30 days or if spread moves >5%).
• Buy a 3‑month USD/INR call spread sized to 1–2% portfolio risk (strike structure to capture 2–6% INR appreciation) to hedge currency exposure and monetize signing‑event moves; cancel if final treaty text (within 30 days) contains CBAM exemptions or major services exclusions.